FDA Inspection
Hubei Haosun Pharmaceutical Co., Ltd.Hubei Haosun Pharmaceutical Co., Ltd. – FDA Inspection, Aug 1, 2025
Record Details
This FDA Inspection record concerns Hubei Haosun Pharmaceutical Co., Ltd., with an inspection on August 1, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 6156ac7f-e283-400a-a016-0393c05bf7c5
Inspection Facts
- Inspection number
- 1280335
- FDA center
- Human Drugs
Other FDA inspections of Hubei Haosun Pharmaceutical Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 2, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 15, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 16, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hubei Haosun Pharmaceutical Co., Ltd.
- FDA Inspection 1047621 - 2018-03-09
- FDA Inspection 988662 - 2016-09-02
- FDA Inspection 867397 - 2013-11-15
- FDA Inspection 738545 - 2011-07-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.